Policy Archives – Treatment Action Group

Consultancy to Expand Donor Country Fiscal Commitments for Tuberculosis R&D

June 10, 2022
Dorrit Walsh

TAG is seeking a consultant to advance strategic policy advocacy and resource mobilization efforts for TB R&D, specifically for new TB vaccines and by positioning TB within global efforts to curb anti-microbial resistance (AMR).

First Page Of TAG And MSF Brief: Realizing Returns On U.S. Government Investment In GeneXpert Diagnostic Technologies

Realizing Returns on U.S. Government Investments in GeneXpert Diagnostic Technologies

September 15, 2021
Dorrit Walsh

GeneXpert diagnostic tests are essential tools in the struggle against COVID-19, tuberculosis, HIV, viral hepatitis, and other diseases. This brief outlines actionable steps the U.S. government can take to hold Cepheid accountable for transparent, fair, and equitable pricing of GeneXpert tests.

TAG Welcomes the Election of Joseph R. Biden Jr. and Kamala D. Harris

November 9, 2020
Dorrit Walsh

Treatment Action Group (TAG) congratulates President-elect Joe Biden and Vice President-elect Kamala Harris on their ascension to the highest offices of the United States. Their victory in both the popular and electoral vote is historic.

Global Health and Human Rights Organizations Say U.S. Withdrawal from WHO Is Reckless Act That Could Delay Americans’ Access to COVID-19 Solutions and Prolong Global Pandemic

July 7, 2020
Dorrit Walsh

AVAC, Health GAP and the Treatment Action Group (TAG) strongly condemn the Trump Administration’s withdrawal from the World Health Organization (WHO).

Treatment Action Group Commemorates Juneteenth through Solidarity Actions, Reflection, and Transparency

June 18, 2020
Dorrit Walsh

Tomorrow, Treatment Action Group (TAG) will be observing and honoring Juneteenth—a commemoration of the end of slavery in the United States—through a day of solidarity, actions, and reflection.

TAG Testimony to NY City Council on Plan for COVID-19 Testing and Contact Tracing

May 19, 2020
Dorrit Walsh

On May 15, TAG Executive Director Mark Harrington presented this testimony to the New York City Council Committee on and Health and the New York Council Committee on Hospitals on Oversight: NYC's Plan for COVID-19 Testing and Contact Tracing.

Global Health and Human Rights Organizations Denounce Trump Administration Decision to Pull Commitments to WHO during COVID-19 Crisis

April 16, 2020
Dorrit Walsh

AVAC, Health GAP, Knowledge Ecology International (KEI), and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.

From Fair Share to Fair Shot: Capitalizing on Opportunities to Ensure Success of U.S.-Government-Funded TB Research

April 10, 2020
Dorrit Walsh

This policy brief discusses the impact of underfunding TB research led by U.S. government agencies. The brief explores several prospective opportunities for TB R&D that would be made possible with increased funding, with recommendations on where policymakers and appropriators can make key investments to U.S. government agencies to advance crucial science on TB diagnostics, treatments, and vaccines.

Science-Based Activism to End Epidemics, from AIDS to COVID-19

March 25, 2020
Dorrit Walsh

We hope you’re staying safe and sanitized during this difficult time! Here at TAG, we’re fortunate to be able to safely work from home, and advance the fight against HIV, tuberculosis, and hepatitis C — and now against COVID-19.

Statement from the ACT NOW:END AIDS Coalition on President Trump’s State of the Union Commitment to Eradicate AIDS

February 5, 2020
Dorrit Walsh

The ACT NOW:END AIDS Coalition, of which TAG is a founding member, released this statement today calling for the administration’s efforts to end the HIV epidemic to be rooted in fact, science, and sensible policies that are consistent with the stated goal of ending HIV.